Biotechnology: CRISPR – Cas becoming more human

Nature Reviews Drug Discovery 16, 601 (2017). doi:10.1038/nrd.2017.167 Author: Kim Baumann In the past few years, the CRISPR–Cas technology has been developed to precisely edit genomic DNA; so far, these approaches have been used mainly in cultured cells or in animal embryo models, but only a few studies have reported their use in human embryos. Ma
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: Research Highlight Source Type: research